Riskpilot← Back to searchSign inGet full accessHeMaCon 4Y AB
ABActiveOrg 5566692439Vitmossevägen 1Accounting, bookkeeping and auditing activities; tax consultancy · NACE 6920Est. 20041-4 employees
Revenue 2025
SEK 1,3M
+10% vs 2024
EBITDA margin
17.9%
+55% vs 2024
Equity ratio
9.9%
Financial strength
Net profit 2025
SEK 62K
+66% vs 2024
| Revenue | SEK 1,3M | +10% |
| EBITDA | SEK 232K | +55% |
| Net profit | SEK 62K | +66% |
| Total assets | SEK 2M | +5% |
| Equity | SEK 200K | +45% |
| Employees | — | — |
Legal name
HeMaCon 4Y AB
Org number
5566692439
Legal form
Aktiebolag
NACE code
6920 · Accounting, bookkeeping and auditing activities; tax consultancy
Founded
26 oktober 2004
Share capital
SEK 100 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva konsultverksamhet inom redovisningstjänster. Dessutom skall bolaget bedriva verksamhet inom förvaltning av fastigheter, bostadsrätter och samt uthyrning av lokaler och kontor. och därmed förenlig verksamhet.
Address
Vitmossevägen 1
Email
helene@hemacon.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 295 | 565 | 466 | — | 947 | 991 | 1 176 | 1 293 |
| Staff expenses | — | — | — | — | — | — | −654 | −685 | −726 | −788 |
| EBITDA | 82 | 3 | 23 | 88 | −19 | 0 | −4 | 87 | 149 | 232 |
| Depreciation & amort. | −10 | −0 | −0 | −0 | −0 | — | −27 | −47 | −49 | −61 |
| EBIT | 72 | 3 | 23 | 88 | −19 | 0 | −31 | 40 | 100 | 170 |
| Net financials | — | — | 3 | — | — | — | −14 | −48 | −48 | −53 |
| Profit before tax | 72 | 3 | 26 | 88 | −18 | 0 | −45 | −8 | 52 | 83 |
| Tax | −0 | −0 | −0 | −0 | −0 | — | — | −1 | −15 | −21 |
| Net profit | 72 | 3 | 26 | 88 | −18 | — | −45 | −9 | 37 | 62 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 185 | 189 | 235 | 388 | 321 | — | 1 975 | 1 985 | 1 921 | 2 015 |
| Equity | 143 | 146 | 172 | 260 | 241 | — | 210 | 201 | 138 | 200 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | — | 1 663 | 1 659 | 1 670 | 1 637 |
| Short-term debt | 42 | 43 | 63 | 128 | 80 | — | 102 | 126 | 113 | 145 |
| Total debt | 42 | 43 | 63 | 128 | 80 | — | 1 765 | 1 785 | 1 783 | 1 781 |
EBITDA margin
17.9%
This company
15.8%
Market median
+13% vs market
20162025
Equity ratio
9.9%
This company
38.2%
Market median
-74% vs market
20162025
Return on equity
31.0%
This company
18.4%
Market median
+68% vs market
20162025
Net profit margin
4.8%
This company
8.1%
Market median
-41% vs market
20162025
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20162025
Debt / equity
9.09×
This company
0.62×
Market median
-1366% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2024 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HeMaCon 4Y AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Jan Erik Jörnelius | Deputy Board Member | 0 companies |
| Jonas Thomas Buchar | Deputy Board Member | 0 companies |
| Hampus Sjö | Deputy Board Member | 0 companies |
| Helene Margareta Jörnelius | Board of Directors | 0 companies |
| Solveig Margareta Sjö | Deputy Board Member | 0 companies |